| Treatment for brain metastases: ASCO-SNO-ASTRO guideline MA Vogelbaum, PD Brown, H Messersmith, PK Brastianos, S Burri, ... Neuro-oncology 24 (3), 331-357, 2022 | 349 | 2022 |
| Radiation therapy for brain metastases: ASCO guideline endorsement of ASTRO guideline D Schiff, H Messersmith, PK Brastianos, PD Brown, S Burri, IF Dunn, ... Journal of Clinical Oncology 40 (20), 2271-2276, 2022 | 39 | 2022 |
| Banking act of 1933 (glass-Steagall) J Maues Federal Reserve History, November 22, 2013 | 36 | 2013 |
| Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines SM Chang, H Messersmith, M Ahluwalia, D Andrews, PK Brastianos, ... Neuro-oncology 21 (4), 424-427, 2019 | 32 | 2019 |
| Promoting scientist–advocate collaborations in cancer research: why and how JM Salamone, W Lucas, SB Brundage, JN Holloway, SM Stahl, ... Cancer research 78 (20), 5723-5728, 2018 | 30 | 2018 |
| Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines SM Chang, H Messersmith, M Ahluwalia, D Andrews, PK Brastianos, ... Journal of Clinical Oncology 37 (13), 1130, 2019 | 24 | 2019 |
| The evolution of clinical trials in metastatic breast cancer: design features and endpoints that matter AD Seidman, J Maues, T Tomlin, V Bhatnagar, JA Beaver American Society of Clinical Oncology Educational Book 40, 44-54, 2020 | 13 | 2020 |
| HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 F Brasó-Maristany, G Griguolo, N Chic, T Pascual, L Paré, J Maues, ... JNCI: Journal of the National Cancer Institute 115 (3), 332-336, 2023 | 9 | 2023 |
| Are small businesses the biggest producers of jobs? KL Kliesen, JS Maues The Regional Economist, 8-9, 2011 | 9 | 2011 |
| Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC) AL Loeser, L Gao, A Bardia, ME Burkard, KM Kalinsky, J Peppercorn, ... Breast Cancer Research and Treatment 196 (3), 549-563, 2022 | 4 | 2022 |
| A comprehensive single-cell breast tumor atlas defines cancer epithelial and immune cell heterogeneity and interactions predicting anti-PD-1 therapy response L Xu, K Saunders, H Knutsdottir, K Chen, J Maués, C Hodgdon, ... bioRxiv, 2022.08. 01.501918, 2022 | 4 | 2022 |
| A qualitative study of the impact of the COVID-19 pandemic on metastatic breast cancer care J Woods, SNC Elmore, L Glenn, J Maues, D James, ML Roberson Journal of Patient Experience 10, 23743735231167973, 2023 | 2 | 2023 |
| Abstract P4-10-09: Patient-centered dosing: Oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer … AL Loeser, A Bardia, ME Burkard, KM Kalinsky, J Peppercorn, HS Rugo, ... Cancer Research 82 (4_Supplement), P4-10-09-P4-10-09, 2022 | 2 | 2022 |
| Why is economic mobility in Memphis among the lowest in the nation A Badel, JS Maues, A Badel, JS Maues Reg Econ, 2014 | 2 | 2014 |
| A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response L Xu, K Saunders, SP Huang, H Knutsdottir, K Martinez-Algarin, I Terrazas, ... Cell Reports Medicine, 2024 | 1 | 2024 |
| The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment … A Loeser, JS Kim, J Peppercorn, ME Burkard, A Niemierko, D Juric, ... JCO Oncology Practice, OP. 23.00539, 2024 | 1 | 2024 |
| Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research H Stires, I Bado, T Brown, M Carlson, IS Chan, GV Echeverria, AJ Ewald, ... npj Breast Cancer 8 (1), 75, 2022 | 1 | 2022 |
| Promise and Perils of Large Language Models for Cancer Survivorship and Supportive Care DS Bitterman, A Downing, J Maués, M Lustberg Journal of Clinical Oncology 42 (14), 1607-1611, 2024 | | 2024 |
| Abstract PO5-06-13: Impact of Therapy on Sites of Metastases in Triple Negative Breast Cancer H Chang, P Dev, L Froessl, SP Huang, C Hodgdon, J Maues, I Chan Cancer Research 84 (9_Supplement), PO5-06-13-PO5-06-13, 2024 | | 2024 |
| Abstract PO4-14-10: Circulating Tumor DNA as a Biomarker for ADCs in Metastatic Breast Cancer H Chang, I Anawate, A Low, SP Huang, J Maues, C Hodgdon, I Chan Cancer Research 84 (9_Supplement), PO4-14-10-PO4-14-10, 2024 | | 2024 |
